{
  "report_rows": [
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.36 vs. cons $0.36",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.82B vs. cons $2.84B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~10.7% vs. cons 10.8%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted EPS midpoint",
      "prediction": "BETTER",
      "answer": "guide ~$1.95 vs. cons $1.91 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY2026 revenue midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$11.30B vs. cons $11.35B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Q3 adjusted EPS commentary",
      "prediction": "LOWER",
      "answer": "guide ~$0.50 vs. cons $0.53 (2026Q3)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -6.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Q3 commentary of ~$0.50 vs. consensus $0.53 would force near-term estimate cuts despite maintaining FY2026 EPS guidance at a ~$1.95 midpoint vs. consensus $1.91; the implied Q4 step-up remains aggressive, so revisions should continue after an initially in-line print.",
  "day5_confidence": "MEDIUM"
}